Bayer Aktiengesellschaft  / Key word(s): Change of Personnel/Strategic Company Decision

18.09.2015 19:00

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Leverkusen, September 18, 2015 

On Friday, the Supervisory Board of Bayer AG approved the reorganization
proposed by the Board of Management. From January 1, 2016, the company's
business will be managed by three divisions: Pharmaceuticals, Consumer
Health and Crop Science. The present structure of a strategic management
holding company and operational subgroups will be replaced by an integrated
organization under the umbrella of the strong Bayer brand. The aim of the
new organization is to provide the best possible support to Bayer's
strategy as a leading Life Science company and to put Bayer in an even
stronger position vis-à-vis its competitors.

In the new organization, the Board of Management of Bayer AG will also hold
overall responsibility for business operations. For this reason, the
Supervisory Board resolved to appoint the heads of the divisions - Dieter
Weinand (Pharmaceuticals), Erica Mann (Consumer Health) and Liam Condon
(Crop Science) - to the Board of Management effective January 1, 2016. On
the same date, Dr. Hartmut Klusik will also join the Board of Management of
Bayer AG as the new Labor Director and Board member responsible for Human
Resources, Technology and Sustainability. He will succeed Michael König,
who has requested that his contract not be extended. Klusik is currently
responsible for Product Supply on the Board of Management of Bayer
HealthCare AG.

Contact:
Mr. Peter Dahlhoff, Bayer AG, Investor Relations, Phone: +49-214-30-33022,
e-mail: peter.dahlhoff@bayer.com, Fax: 0214-30-96-33022


---------------------------------------------------------------------------

Information and Explaination of the Issuer to this News:

Forward-Looking Statements 
This ad-hoc announcement may contain forward-looking statements based on
current assumptions and forecasts made by Bayer Group or subgroup
management. Various known and unknown risks, uncertainties and other
factors could lead to material differences between the actual future
results, financial situation, development or performance of the company and
the estimates given here. These factors include those discussed in Bayer's
public reports, which are available on the Bayer website at www.bayer.com.
The company assumes no liability whatsoever to update these forward-looking
statements or to conform them to future events or developments.

18.09.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Bayer Aktiengesellschaft
              Kaiser-Wilhelm-Allee 1
              51373 Leverkusen
              Germany
Phone:        +49 (0)214 30-81 013
Fax:          +49 (0)21430-9681013
E-mail:       
Internet:     www.bayer.com
ISIN:         DE000BAY0017
WKN:          BAY001
Indices:      DAX, EURO STOXX 50, Stoxx 50
Listed:       Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime
              Standard), Hamburg, Hanover, Munich, Stuttgart; Terminbörse
              EUREX; Madrid
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------